5 Best Medical Technology Stocks to Buy Right Now

2. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 110

Stock Upside: 49.11%

Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to buy right now. On May 19, TD Cowen reiterated its Buy rating and $80 price target on Boston Scientific Corporation (NYSE:BSX).

TD Cowen constructed its thesis around Boston Scientific’s Fracture IDE study. The study tested the company’s SEISMIQ 4CE Coronary Intravascular Lithotripsy (IVL) Catheter, which is designed to treat severely calcified coronary artery disease (CAD). It uses laser energy inside a balloon catheter to generate acoustic pressure waves that fracture calcium deposits, preparing the vessel for stent implantation

The IDE trial was about testing the device to see if it solves the problem of a poorly expanded stent when removing built up hard calcium deposits in arteries. Boston Scientific said in a press release that the trial proved the safety of the SEISMIQ 4CE. Also, the procedure was a success in over 93% of patients, which means the company proved the device’s effectiveness.

TD Cowen had anticipated positive results from the IDE trial. Particularly, the firm characterized the coronary IVL market as offering double-digit growth and projected it will become a $1.5 billion market in the near term. The firm noted that Boston Scientific’s SEISMIQ 4CE device targets a first-half 2027 US launch if the regulatory process proceeds as planned.

Boston Scientific Corporation (NYSE:BSX) is a medical technology company that develops and manufactures minimally invasive medical devices used in interventional cardiology, electrophysiology, endoscopy, urology, and neuromodulation. Its product portfolio includes coronary stents, cardiac rhythm management devices, ablation systems for treating heart arrhythmias, and advanced endoscopy tools used in diagnostic and therapeutic procedures.

1281292 - 11759070 - 1